Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study

JAMA: The Journal of the American Medical Association

Volumn 271, Issue 11, 1994, Pages 840-844

  Benjamin, Emelia J ^a   Levy, Daniel ^a   Vaziri, Sonya M ^a   D'agostino, Ralph B ^a   Belanger, Albert J ^a   Wolf, Philip A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VALVULAR HEART DISEASE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CAUSALITY; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMAN; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; RISK FACTORS; SEX FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028299731     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03510350050036     Document Type: Article

References (31)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J. 1983;106: 389-396.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983-988.
3. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA. 1981;245: 1540-1544.
4. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham Study. N Engl J Med. 1982; 306:1018-1022.
5. Aberg H. Atrial fibrillation: A review of 463 cases from Philadelphia General Hospital from 1955 to 1965. Acta Med Scand. 1968;184:425-431.
6. Davidson E, Weinberger I, Rotenberg Z, Fuchs J, Agmon J. Atrial fibrillation: Cause and time of onset. Arch Intern Med. 1989;149:457-459.
7. Godtfredsen J. Atrial fibrillation: Course and prognosis—a follow-up study of 1212 cases. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial Fibrillation. Mölndal, Sweden: AB Hassle; 1982:134-145.
8. McEachern D, Baker BM. Auricular fibrillation: Its etiology, age incidence and production by digitalis therapy. Am J Med Sci. 1932;183:35-48.
9. Stroud WD, Laplace LB, Reisinger JA. The etiology, prognosis and treatment of auricular fibrillation. Am J Med Sci. 1932;183:48-60.
10. Sawyer CG, Bolin LB, Stevens EL, Daniel LB, O'Neil NC, Hayes DM. Atrial fibrillation: Its etiology, treatment and association with embolization. South Med J. 1958;51:84-93.
11. Önundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson T. Chronic atrial fibrillation—epidemiologic features and 14-year follow-up: A case control study. Eur Heart J. 1987;8:521-527.
12. Lake FR, Cullen KJ, de Klerk NH, McCall MG, Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med. 1989;19:321-326.
13. Dawber TR, Meadors GF, Moore FE. Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health. 1951;41:279-286.
14. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up. In: Kannel WB, Gordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, DC: Dept of Health, Education, and Welfare; 1974: Section 30. DHEW publication NIH 74-599.
15. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: Prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med. 1969;71:89-105.
16. Cupples LA, D'Agostino RB, Anderson K, Kannel WB. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med. 1988;7:205-218.
17. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham Study. Stat Med. 1990;9:1501-1515.
18. Walker SD. The estimation and interpretation of attributable risk in health research. Biometrics. 1976;32:829-849.
19. Sherman DG, Goldman L, Whiting RB, Jurgensen K, Kaste M, Easton D. Thromboembolism in patients with atrial fibrillation. Arch Neurol. 1984;41:708-710.
20. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol. 1988;61:714-717.
21. Wood P. An appreciation of mitral stenosis, part I: Clinical features. BMJ. 1954;1:1051-1063.
22. Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study. J Am Coll Cardiol. 1990;15:1279-1285.
23. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: Framingham Heart Study. Circulation. 1994;89:724-730.
24. Ettinger PO, Wu CF, De la Cruz C, Weisse AB, Ahmed SS, Rega TJ. Arrhythmias and the 'holiday heart': Alcohol associated cardiac rhythm disorders. Am Heart J. 1978;95:555-562.
25. Petersen P, Godtfredsen J, Boysen G, Andersen ED, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK Study. Lancet. 1989;1:175-179.
26. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990; 323:1505-1511.
27. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: Final results. Circulation. 1991;84:527-539.
28. Ezekowitz MD, Bridgers SL, James KE, et al, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992; 327:1406-1412.
29. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation. 1990;82:1106-1116.
30. Albers GW, Sherman DG, Gress DR, Paulseth JE, Petersen P. Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials. Ann Neurol. 1991;30:511-518.
31. Fihn SD, McDonell M, Martin D, et al, for the Warfarin Optimized Outpatient Follow-up Study Group. Risk factors for complications of chronic aticoagulation: A multicenter study. Ann Intern Ned. 1993;118:511-520.